Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bceffddb90b9b3da8a772212961764b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
filingDate |
2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6088e90a82a2584ca29b653625a6a9a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2452aa341cb040641a93c5f4c5428d8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26105c73781bba0447ec09e54e7081f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b41eafaa98934f838be661a8f0593c1 |
publicationDate |
2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010083760-A |
titleOfInvention |
2-Phenylindole compounds having histamine H2 receptor antagonistic action |
abstract |
The present invention provides a preventive and / or therapeutic agent for upper gastrointestinal inflammatory diseases such as peptic ulcer and acute stress ulcer. The following general formula (1) [In the formula (1), A represents a C 6-10 aryl group, X represents a C 3-6 alkylene group which may be substituted with a hydroxyl group, Y represents a C 1-6 alkylene group, C 2 -6- alkenylene group or C 2-6 alkynylene group] is a histamine H2 receptor antagonist comprising as an active ingredient a 2-phenylindole derivative represented by the above or a salt thereof or a solvate thereof. [Selection figure] None |
priorityDate |
2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |